FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Unilever Q3 sales grow 5.2% as FY volume growth forecast improves

Unilever reported third-quarter underlying sales growth of 5.2%, with turnover rising 6.7% to €13.3 billion. The company now expects at least 3% volume growth in 2026,..

Intertek Q3 revenue rises 7% as company maintains 2026 forecast

Intertek Group reported third-quarter revenue growth of 7% at constant currency, taking year-to-date revenue to £2.7 billion. The company expects mid-single-digit like-for-like revenue growth in 2026,..

GSK reports 5% Q3 sales growth and reaffirms 2026 guidance

GSK reported third-quarter sales of £8.9 billion, up 5% at constant exchange rates, driven by 15% growth in Specialty Medicines. The pharmaceutical group maintained its 2026..

HSBC reports 32% rise in third-quarter pre-tax profit to $9.6 billion

HSBC Holdings reported third-quarter 2026 profit before tax of $9.6 billion, up 32% year-on-year, as revenue increased to $18.6 billion. The bank approved a third interim..

Informa cuts revenue growth outlook to 3%, maintains double-digit earnings growth guidance

Informa reported 6.5% underlying revenue growth for the nine months to September 2026, including 8.0% growth in B2B Live Events...

Reckitt raises full-year sales growth guidance after 3.3% Q3 core revenue growth

Reckitt reported 3.3% like-for-like net revenue growth for Core Reckitt in Q3 2026, with Emerging Markets up 8.0% and Europe returning to growth. The company lowered..

GSK reports 62% response rate in ovarian cancer trial

GSK has reported a confirmed response rate of 62% for its investigational drug mocertatug rezetecan in patients with platinum-resistant ovarian cancer, with median progression-free survival of..

Computacenter raises FY 2026 profit forecast after strong Q3

Computacenter expects adjusted profit before tax of at least £425m for FY 2026, following a third-quarter performance ahead of expectations and a record committed product order..

Rio Tinto to invest $1.9 billion in Queensland bauxite project

Rio Tinto will invest US$1.9 billion to develop the Kangwinan bauxite project in Queensland, increasing Weipa Operations’ annual capacity to around 44 million tonnes. First production..

Barclays reports 12% profit growth, announces £500m share buyback

Barclays reported a 12% increase in third-quarter profit before tax to £2.3bn, with income rising 3% to £7.4bn and return on tangible equity improving to 11.7%...

LSEG raises 2026 guidance after 8.8% Q3 income growth

London Stock Exchange Group reported 8.8% organic income growth in Q3 2026, driven by strong performance in Markets and accelerating subscription businesses. The Group raised its..

RELX reports 7% underlying revenue growth and reaffirms full-year outlook

RELX reported 7% underlying revenue growth for the first nine months of 2026, led by Legal at 10%, Risk at 8% and Scientific, Technical & Medical..

Fresnillo reports 11.6% drop in Q3 silver production

Fresnillo’s Q3 silver production fell 11.6% year-on-year to 10.3 million ounces, while gold production declined 10.7% to 135,053 ounces. The company maintained its 2026 production guidance...

SEGRO reports £70m in new rent and 94.7% occupancy

SEGRO contracted £70m of new headline rent in the first nine months of 2026, up 32% year-on-year, while occupancy increased to 94.7%. Development projects under construction..

Aberdeen Group reports £578.9bn AUMA and strong interactive investor inflows

Aberdeen Group’s AUMA reached £578.9bn at the end of September 2026, while interactive investor recorded £2.5bn in Q3 net inflows, up 32% year-on-year. The Group remains..

GSK wins FDA approval for hepatitis B treatment Hibsago

GSK has received FDA approval for Hibsago (bepirovirsen), a new chronic hepatitis B treatment that achieved a 19% functional cure rate in Phase III trials after..

Bunzl reports 3.7% underlying revenue growth, reiterates full-year outlook

Bunzl delivered 3.7% underlying revenue growth in the third quarter, supported by volume growth in North America and effective management of inflation...

Anglo American maintains 2026 production guidance after resilient Q3 performance

Anglo American reports resilient third-quarter operational performance, with manganese production increasing 6% and steelmaking coal output rising 53% year-on-year. The Group maintains its 2026 production guidance,..

LondonMetric reports 8% rental income growth as portfolio reaches £8bn

LondonMetric Property Plc reports an increase of more than 8% in net rental income to approximately £240 million for the six months to 30 September 2026,..

GSK reports positive global results for lung cancer drug candidate

GSK reports first global data for investigational antibody-drug conjugate risvutatug rezetecan, showing a confirmed objective response rate of 61% at the 8 mg/kg dose in patients..
Search

Funds

FTSE 100

Unilever Q3 sales grow 5.2% as FY volume growth forecast improves

Unilever reported third-quarter underlying sales growth of 5.2%, with turnover rising 6.7% to €13.3 billion. The company now expects at least 3% volume growth in 2026, following strong performance across Home Care, Personal Care and Beauty & Wellbeing...

Intertek Q3 revenue rises 7% as company maintains 2026 forecast

Intertek Group reported third-quarter revenue growth of 7% at constant currency, taking year-to-date revenue to £2.7 billion. The company expects mid-single-digit like-for-like revenue growth in 2026, alongside higher margins, earnings growth and strong free cash flow...

GSK reports 5% Q3 sales growth and reaffirms 2026 guidance

GSK reported third-quarter sales of £8.9 billion, up 5% at constant exchange rates, driven by 15% growth in Specialty Medicines. The pharmaceutical group maintained its 2026 guidance, expecting turnover growth of 3% to 5% and core operating profit growth of 7% to 9%...

HSBC reports 32% rise in third-quarter pre-tax profit to $9.6 billion

HSBC Holdings reported third-quarter 2026 profit before tax of $9.6 billion, up 32% year-on-year, as revenue increased to $18.6 billion. The bank approved a third interim dividend of $0.10 per share and plans a further share buyback of up to $1 billion, while maintaining its 2026 return on tangible equity target of at least 17%...

Informa cuts revenue growth outlook to 3%, maintains double-digit earnings growth guidance

Informa reported 6.5% underlying revenue growth for the nine months to September 2026, including 8.0% growth in B2B Live Events...

Reckitt raises full-year sales growth guidance after 3.3% Q3 core revenue growth

Reckitt reported 3.3% like-for-like net revenue growth for Core Reckitt in Q3 2026, with Emerging Markets up 8.0% and Europe returning to growth. The company lowered its full-year outlook range to 3.5% to 4.5% growth, reflecting manufacturing constraints affecting Lysol and slower growth in China’s vitamins, minerals and supplements category...

GSK reports 62% response rate in ovarian cancer trial

GSK has reported a confirmed response rate of 62% for its investigational drug mocertatug rezetecan in patients with platinum-resistant ovarian cancer, with median progression-free survival of 11.1 months in the Phase I BEHOLD-1 trial...

Computacenter raises FY 2026 profit forecast after strong Q3

Computacenter expects adjusted profit before tax of at least £425m for FY 2026, following a third-quarter performance ahead of expectations and a record committed product order backlog of £12.6bn...

Rio Tinto to invest $1.9 billion in Queensland bauxite project

Rio Tinto will invest US$1.9 billion to develop the Kangwinan bauxite project in Queensland, increasing Weipa Operations’ annual capacity to around 44 million tonnes. First production is targeted for 2029, with construction expected to support more than 1,300 jobs...

Barclays reports 12% profit growth, announces £500m share buyback

Barclays reported a 12% increase in third-quarter profit before tax to £2.3bn, with income rising 3% to £7.4bn and return on tangible equity improving to 11.7%. The bank announced a £500m share buyback, taking year-to-date shareholder distributions to £2.8bn, up 46% year-on-year, and reaffirmed its 2026 and 2028 financial targets...

LSEG raises 2026 guidance after 8.8% Q3 income growth

London Stock Exchange Group reported 8.8% organic income growth in Q3 2026, driven by strong performance in Markets and accelerating subscription businesses. The Group raised its full-year income growth guidance to at least 8%, increased its EBITDA margin expansion outlook to 100-120 basis points and expects equity free cash flow of at least £2.8bn...

RELX reports 7% underlying revenue growth and reaffirms full-year outlook

RELX reported 7% underlying revenue growth for the first nine months of 2026, led by Legal at 10%, Risk at 8% and Scientific, Technical & Medical at 6%. The group expects another year of strong underlying revenue and adjusted operating profit growth, supported by continued demand for AI-enabled analytics and decision tools...

Fresnillo reports 11.6% drop in Q3 silver production

Fresnillo’s Q3 silver production fell 11.6% year-on-year to 10.3 million ounces, while gold production declined 10.7% to 135,053 ounces. The company maintained its 2026 production guidance...

SEGRO reports £70m in new rent and 94.7% occupancy

SEGRO contracted £70m of new headline rent in the first nine months of 2026, up 32% year-on-year, while occupancy increased to 94.7%. Development projects under construction or in advanced negotiations now represent £103m of potential rent...

Aberdeen Group reports £578.9bn AUMA and strong interactive investor inflows

Aberdeen Group’s AUMA reached £578.9bn at the end of September 2026, while interactive investor recorded £2.5bn in Q3 net inflows, up 32% year-on-year. The Group remains confident of meeting its FY26 adjusted operating profit target of at least £300m...

GSK wins FDA approval for hepatitis B treatment Hibsago

GSK has received FDA approval for Hibsago (bepirovirsen), a new chronic hepatitis B treatment that achieved a 19% functional cure rate in Phase III trials after six months of treatment...

Bunzl reports 3.7% underlying revenue growth, reiterates full-year outlook

Bunzl delivered 3.7% underlying revenue growth in the third quarter, supported by volume growth in North America and effective management of inflation...

Anglo American maintains 2026 production guidance after resilient Q3 performance

Anglo American reports resilient third-quarter operational performance, with manganese production increasing 6% and steelmaking coal output rising 53% year-on-year. The Group maintains its 2026 production guidance, lowers Copper Peru unit cost guidance to approximately 50 cents per pound and raises De Beers production guidance to 25-28 million carats...

LondonMetric reports 8% rental income growth as portfolio reaches £8bn

LondonMetric Property Plc reports an increase of more than 8% in net rental income to approximately £240 million for the six months to 30 September 2026, supported by acquisitions, rent reviews and leasing activity..

GSK reports positive global results for lung cancer drug candidate

GSK reports first global data for investigational antibody-drug conjugate risvutatug rezetecan, showing a confirmed objective response rate of 61% at the 8 mg/kg dose in patients with relapsed extensive-stage small cell lung cancer...
Search

Funds

FTSE 100

FTSE 100

Funds